Utilization of Target Ranges to Treat Parkinson's Disease With the PKG
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Raja Mehanna, MD
The University of Texas Health Science Center, Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington Regional Medical Center
Fayetteville, Arkansas, United States
- University of Arkansas Medical Center
Little Rock, Arkansas, United States
- Parkinson'S Disease and Movement Disorders Center of Silicon Valley
Menlo Park, California, United States
- Parkinson'S Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, United States
- University of Florida
Gainesville, Florida, United States
- University of South Florida
Tampa, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Kaiser Mid-Atlantic Permanente Center
Rockville, Maryland, United States
- Neurology Center of New England
Foxborough, Massachusetts, United States
- Michigan State University
East Lansing, Michigan, United States
- University of Nebraska
Omaha, Nebraska, United States
- Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada, United States
- Parkinson'S Disease and Movement Disorders Center of Long Island
Commack, New York, United States
- Weill Cornell
New York, New York, United States
- University of Texas
Houston, Texas, United States
- Marshall University
Huntington, West Virginia, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Oct 2019
- Primary completion
- 16 Oct 2020
- Completion
- 16 Oct 2020
- Last update posted
- 8 Feb 2022
- Registered enrollment
- 41
- Registry id
- NCT03984305
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.